Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TNT-SHORT in Gastric Cancer
NCT07101666Phase 2Not yet recruiting
- Sponsor
- Washington University School of Medicine
- Start
- Oct 2026
- Primary completion
- Apr 2031
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial in gastric cancer (GC), sponsored by Washington University School of Medicine. Primary endpoint: Complete Response at 18 months. Planned start Oct 2026; status: not yet recruiting.
02
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT07101666.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07101666.